Canada markets close in 2 hours 25 minutes

Sirona Biochem Corp. (SBM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1500-0.0100 (-6.25%)
As of 09:34AM EDT. Market open.
Full screen
Previous Close0.1600
Bid0.1400 x 0
Ask0.1600 x 0
Day's Range0.1500 - 0.1550
52 Week Range0.1400 - 0.3500
Avg. Volume39,122
Market Cap37.7M
Beta (5Y Monthly)-0.68
PE Ratio (TTM)N/A
EPS (TTM)-0.0160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 27, 2006
1y Target EstN/A
  • GlobeNewswire

    Sirona Biochem Issues Corporate Update

    VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces the release of a corporate update which highlights the company’s recent team meeting in France, the current pipeline, and the latest deal structure. With the success of the licensing deal with AbbVie, the company needs to prepare for its next phase of growth. Dr. Wolfgang Bieber reports “In my professional opinion, as a chemist of over three decades, I

  • GlobeNewswire

    Sirona Biochem Corporate Update

    VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides the following update: Dear shareholders, We are pleased to provide an outlook of our ongoing corporate development. On June 13th we announced that we had successfully completed an exclusive global license for TFC-1067 and related family of compounds with Allergan Aesthetics (an AbbVie company). This deal represents a major milestone for Sirona and one we ha

  • GlobeNewswire

    Sirona Biochem Contracts WuXi AppTec to Manufacture Revolutionary Anti-Aging/Anti-Wrinkle Compound for Clinical Trial

    VANCOUVER, British Columbia, June 22, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with Contract Manufacturing Organization (CMO) WuXi AppTec (“WuXi”), Shanghai, for the small-scale production of TFC-1326, a powerful active against the aging effects on skin. Years of groundbreaking research by Sirona’s team of scientists at TFChem has shown in preclinical studies that TFC-1326 has the potentia